Trial watch: Adaptive BATTLE trial uses biomarkers to guide lung cancer treatment.
D014408:Biomarkers, Tumor / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*
D014408:Biomarkers, Tumor